Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
181
-
Total shares
-
61M
-
Shares change
-
+6.33M
-
Total reported value, excl. options
-
$1.83B
-
Value change
-
+$195M
-
Put/Call ratio
-
1.13
-
Number of buys
-
89
-
Number of sells
-
-95
-
Price
-
$29.99
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q2 2014
186 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q2 2014.
IMPAX LABORATORIES INC - COM (IPXL) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5.42M shares), BlackRock Fund Advisors (4.68M shares), VANGUARD GROUP INC (4.4M shares), FMR LLC (3.78M shares), Invesco Ltd. (3.19M shares), State Street Corp (2.35M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (2.19M shares), BlackRock Institutional Trust Company, N.A. (1.89M shares), JENNISON ASSOCIATES LLC (1.72M shares), and Ameriprise Financial Inc (1.57M shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.